series-c
Stage
About
Amazentis is a Swiss longevity biotech company that develops clinically validated Urolithin A-based nutritional and skincare products targeting mitochondrial health and healthy aging.
Explore Amazentis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.